Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease
The Analyst · 2026 · 151 (6) · 1639-1649
DOI: 10.1039/d5an00961h ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2026. Verfasst von Jiaxin Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Medical University, Hefei 230032, China. qlzhang@ahmu.edu.cn. Hauptthemen laut MEDLINE: Parkinson Disease, Metabolomics, Neurotransmitter Agents, Amino Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Targeted UPLC-MS/MS shows widespread serum amino acid and neurotransmitter shifts in Parkinson's disease: Gly/Ser drops, Pro rises, and arginine biosynthesis plus glyoxylate and Gly/Ser/Thr metabolism emerge as linked pathways of progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Medical University, Hefei 230032, China. qlzhang@ahmu.edu.cn.
- Department of Pharmacy, Fuyang People's Hospital, Fuyang 236000, China.
- The Center for Scientific Research of Anhui Medical University, Hefei 230032, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China.
Zitieren
APA
Yang, J., Wu, D., Wang, Z., Zhang, Z., Zheng, X., Wang, S., Huang, F., Song, S., & Zhang, Q. (2026). Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease. The Analyst, 151(6), 1639-1649. https://doi.org/10.1039/d5an00961h
Vancouver
Yang J, Wu D, Wang Z, Zhang Z, Zheng X, Wang S, et al. Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease. The Analyst. 2026;151(6):1639-1649. doi:10.1039/d5an00961h
BibTeX
@article{Yang2026,
author = {Yang, Jiaxin and Wu, Dong and Wang, Zhiwei and Zhang, Zhijing and Zheng, Xiaowen and Wang, Sheng and Huang, Fen and Song, Shuai and Zhang, Qunlin},
title = {Targeted serum metabolomics reveals alterations in amino acid and neurotransmitter pathways in Parkinson's disease},
journal = {The Analyst},
year = {2026},
volume = {151},
number = {6},
pages = {1639--1649},
doi = {10.1039/d5an00961h}
}
EUVIMED